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NADPH oxidase and reactive oxygen species
contribute to alcohol-induced microglial
activation and neurodegeneration
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Abstract
Background: Activation of microglia causes the production of proinflammatory factors and upregulation of
NADPH oxidase (NOX) that form reactive oxygen species (ROS) that lead to neurodegeneration. Previously, we
reported that 10 daily doses of ethanol treatment induced innate immune genes in brain. In the present study, we
investigate the effects of chronic ethanol on activation of NOX and release of ROS, and their contribution to
ethanol neurotoxicity.
Methods: Male C57BL/6 and NF-B enhanced GFP mice were treated intragastrically with water or ethanol (5 g/kg,
i.g., 25% ethanol w/v) daily for 10 days. The effects of chronic ethanol on cell death markers (activated caspase-3
and Fluoro-Jade B), microglial morphology, NOX, ROS and NF-B were examined using real-time PCR,
immunohistochemistry and hydroethidine histochemistry. Also, Fluoro-Jade B staining and NOX gp91phox
immunohistochemistry were performed in the orbitofrontal cortex (OFC) of human postmortem alcoholic brain
and human moderate drinking control brain.
Results: Ethanol treatment of C57BL/6 mice showed increased markers of neuronal death: activated caspase-3 and
Fluoro-Jade B positive staining with Neu-N (a neuronal marker) labeling in cortex and dentate gyrus. The OFC of
human post-mortem alcoholic brain also showed significantly more Fluoro-Jade B positive cells colocalized with
Neu-N, a neuronal marker, compared to the OFC of human moderate drinking control brain, suggesting increased
neuronal death in the OFC of human alcoholic brain. Iba1 and GFAP immunohistochemistry showed activated
morphology of microglia and astrocytes in ethanol-treated mouse brain. Ethanol treatment increased NF-B
transcription and increased NOX gp91phox at 24 hr after the last ethanol treatment that remained elevated at 1
week. The OFC of human postmortem alcoholic brain also had significant increases in the number of gp91phox +
immunoreactive (IR) cells that are colocalized with neuronal, microglial and astrocyte markers. In mouse brain
ethanol increased gp91phox expression coincided with increased production of O2
- and O2
- - derived oxidants.
Diphenyleneiodonium (DPI), a NOX inhibitor, reduced markers of neurodegeneration, ROS and microglial activation.
Conclusions: Ethanol activation of microglia and astrocytes, induction of NOX and production of ROS contribute
to chronic ethanol-induced neurotoxicity. NOX-ROS and NF-B signaling pathways play important roles in chronic
ethanol-induced neuroinflammation and neurodegeneration.
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Background
Alcohol can cause brain damage [1] and lead to neuro-
degeneration in some cases [2]. Alcoholics, likely due to
heavy alcohol consumption have reduced brain mass,
cortical neuronal loss, other neuropathological changes
as well as impaired cognitive functions and mild demen-
tia [3-5]. Binge ethanol administration in adult rats is
known to cause brain damage reduced by anti-oxidants
[6-8]. However, the mechanism of ethanol induced neu-
rodegeneration is uncertain. Previous work from our
laboratory found 10 daily doses of ethanol treatment to
male mice induced microglial activation, increased
proinflammatory cytokines (TNFa, IL-1b, IL-6 etc.) and
chemokines (MCP-1) and up-regulated NOX, resulting
in production of ROS [9]. We also found increased
microglial markers and levels of the chemokine, MCP-1,
in post-mortem human alcoholic brain [10]. Others
studying female mice following 5 months of ethanol
drinking found chronic ethanol activation of nuclear fac-
tor kappa-B (NF-B) pathways, markers of increased
microglia and astrocyte activation, induction of the
proinflammatory oxidases, inducible nitric oxide
synthase, and cyclo-oxygenase COX-2, as well as
increased cytokine levels in the cerebral cortex that
were related to increased activated caspase-3, a marker
of cell death [11]. In the present study, in male mice, we
investigate NF-B, NADPH oxidase (NOX) and ROS
involvement in neuronal damage.
NF-B is a transcription factor that in brain is
involved in proinflammatory gene activation in glia as
well as other gene regulation. Acute ethanol treatment
of rats activates NF-B in the brain [12]. Chronic binge
ethanol treatment of rats causes neuronal degeneration
and increased NF-B-DNA binding, with both being
reversed by inhibition of NF-B-DNA binding [13].
Ethanol treatment of brain slice cultures has been found
to increase multiple NF-B proinflammatory target
genes [14,15]. However, the relationship between proin-
flammatory gene induction and neuronal death is not
clearly understood. Activation of glial cells, especially
microglia, that release pro-inflammatory factors and
reactive oxygen species (ROS) have been implicated in
several models of neurodegeneration [16,17]. NADPH
oxidase (NOX), an enzyme that produces ROS, is acti-
vated in brains from Alzheimer’s disease (AD) [18] and
Parkinson’s disease (PD) [19]. NOX is a multi-subunit
enzyme complex that is activated and induced by
inflammatory signals [20,21]. The catalytic subunit of
NOX, gp91phox, produces superoxide that can be toxic
to neurons. In the present study, we find increased
levels of NOX-gp91phox, and reactive oxygen species
(ROS) following chronic ethanol treatment. Using trans-
genic mice that mark NF-B transcription through
induction of enhanced GFP mice (NF-BEGFP) [22,23]
we find NF-B transcription, NOX gp91phox activation
and ROS production occur within the same cell.
Further, increased levels of NOX-gp91phox and cell
death markers within orbital frontal cortex (OFC) are
found in both chronic ethanol treated mouse and
human post-mortem alcoholic brain. Our data indicate
ethanol activation of NF-B transcription of proinflam-
matory genes and formation of NOX-ROS play a pivotal
role in ethanol induced neurodegeneration.
Methods
Animals
Eight-week male (20-22g) C57BL/6 mice were purchased
from Jackson Laboratories (Bar Harbor, Maine). NF-B
enhanced GFP mice were gift from Dr. Christian Jobin’s
lab. All protocols in this study were approved by the
Institutional Animal Care and Use Committee and were
in accordance with the National Institute of Health reg-
ulations for the care and use of animals in research.
Human tissue
Human post-mortem brain tissue was obtained from the
New South Wales Tissue Resource Center in Australia
[ethics committee approval number: X11-0107]. Paraffin
sections of orbitofrontal cortex (OFC) were used in this
study. The detailed patients’ medical history is presented
in Table 1. Human alcoholic patients averaged with life-
time consumption of over 500 Kg of ethanol were com-
pared to moderate drinkers who averaged less than 1
drink per day with lifetime consumption of less than
100 Kg of ethanol. Alcoholic neurodegeneration is asso-
ciated with chronic high levels of alcohol consumption,
whereas, there is no neurodegeneration associated with
moderate drinkers [24-26]. Only individuals with alcohol
dependence not complicated by liver cirrhosis or nutri-
tional deficiencies were included in this study. The main
causes of death were cardiovascular disease for both
groups. Complete life-style, medical histories and brain
function as well as post-mortem interval (the time
between death and the brain was removed from the
body); causes of death and alcohol consumption are
documented. Tobacco smoking history is also documen-
ted. Tobacco smoking is common in alcoholism and
often confounds studies of alcoholism. Within our
human subjects 6 of 8 controls and alcoholics had a his-
tory of smoking, although 3 controls were ex-smokers
whereas all 6 smoking alcoholics continued to smoke.
All psychiatric and alcohol use disorder diagnoses are
confirmed using the Diagnostic Instrument for Brain
Studies that is compliant with the Diagnostic Statistical
Manual of Mental Disorders and has demonstrated
reliability [27].
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Reagents
Cleaved caspase-3 (Asp 175) antibody was from Cell
Signaling Technology (Danvers, MA). Fluoro-Jade B and
mouse Neu-N antibody were from Chemicon interna-
tional (Temecula, CA). Rabbit anti-Iba1 antibody was
purchased from Wako Pure Chemical Industries, Ltd.
(1-2Doshomachi 3-Chome Chuo-ku Osaka 540-8605,
Japan). Monoclonal anti-mouse gp91phox was from
Transduction Laboratories (Lexington, KY). Rabbit poly-
clonal anti-gp91phox IgG was purchased from Upstate
cell signaling solutions (Temecula, CA). Goat polyclonal
gp91phox (C-15) antibody was purchased from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit poly-
clonal microtubule associated protein 2 (MAP2) anti-
body was purchased from Abcam (Cambridge, MA).
Polyclonal Rabbit anti-Glial Fibrillary Acidic Protein was
from DakoCytomation (Glostrup, Denmark). Hydroethi-
dine was from Invitrogen Molecular Probes (Eugene,
OR). All other reagents came from Sigma Chemical Co.
(St. Louis, MO).
Drug treatments
Sixty male C57BL/6 mice were randomly assigned to
water control group (30 mice) and ethanol group (30
mice). The mice were treated intragastrically with water
(control) or ethanol (5 g/kg, i.g., 25% ethanol w/v), with
volumes matched, daily for 10 days. The average blood
alcohol concentration at 1 hour after the first ethanol
treatment and the last ethanol treatment was 302 mg/dl
± 12 (w/v, n = 10) and 297 mg/dl ± 11 (w/v, n = 10),
respectively. The blood ethanol level is high and consid-
ered to model binge drinking [28]. Twenty mice from
each group were sacrificed at 24 hr after the last dose of
ethanol for mRNA and histochemistry. Ten mice from
each group were sacrificed at 1 week after the last dose
of ethanol for NOX gp91phox immunostaining. For
diphenyleneiodonium (DPI) treatment, forty male
C57BL/6 mice were randomly assigned to 4 groups:
control, EtOH, DPI and EtOH plus DPI (10 mice per
group). The mice in EtOH and EtOH plus DPI groups
were treated intragastrically with ethanol (5 g/kg, i.g.,
25% ethanol w/v) daily for 10 days. The mice in control
and DPI groups were gavaged with water daily for 10
days. DPI (3 mg/kg, i.p.) was given to mice at 0.5 hr and
24 hr after the last dose of ethanol. In both water and
ethanol groups, mice were injected with saline, with
volumes and time matched. Mice were sacrificed 3 hr
after the last dose of DPI. For NF-B transcription
Table 1 Case characteristics of Subjects used for immunohistochemical analyses - Alcohol Consumption
Group Patients Age at
Death
Sex PMI Clinical Cause of Death Lifetime Ethanol
(gm)
Lifetime
Drinks
Drinks/
Yr
Drinks/
Day
Control 1 44 Male 50 Ischaemic heart disease 69000 4929 259 0.71
Control 2 46 Male 29 Acute myocardial infarction 17300 1236 73 0.20
Control 3 48 Male 24 Ischaemic heart disease 59000 4214 183 0.50
Control 4 50 Male 30 Coronary heart disease 5500 393 16 0.04
Control 5 50 Male 40 Haemopericardium 9000 643 26 0.07
Control 6 53 Male 16 Dilated cardiomyopathy 102000 7286 260 0.71
Control 7 60 Male 28 Ischaemic heart disease 0 0 0 0.00
Control 8 62 Male 46 Ischaemic heart disease 5000 357 10 0.03
Alcoholic 1 44 Male 15 Ischaemic heart disease 639000 45643 1902 5
Alcoholic 2 45 Male 7.5 Drowning 1271000 90786 3026 8
Alcoholic 3 49 Male 44 Ischaemic heart disease 1181000 84357 2556 7
Alcoholic 4 49 Male 16 Coronary artery thrombosis 1278000 91286 2608 7
Alcoholic 5 50 Male 17 Ischaemic heart disease 1958000 139857 4371 12
Alcoholic 6 51 Male 27 Gastro intestinal haemorrhage 1863000 133071 3914 11
Alcoholic 7 61 Male 59 Myocarditis 5811000 415071 9224 25
Alcoholic 8 61 Male 23.5 Atherosclerotic cardiovascular
disease
3158000 225571 5127 14
Brains were collected by the New South Wales Tissue Resource Center brain donor program at the University of Sydney. Complete life-style, medical histories and
brain function as well as post-mortem interval (PMI, the time between death and the brain was removed from the body), causes of death and alcohol drinking
histories are documented. Among these patients controls averaged less than 1 drink per day whereas alcoholics averaged over 10 drinks per day. Alcoholic
neurodegeneration is associated with chronic high levels of alcohol consumption, whereas, there is no neurodegeneration associated with moderate drinkers is
related to lifetime alcohol consumption [24-26]. Tobacco smoking history is also documented. Tobacco smoking is commone in alcoholism and often confounds
studies of alcoholism. Within our human subjects 6 of 8 controls and alcoholics had a history of smoking, although 3 controls were ex-smokers whereas all 6
smoking alcoholics continued to smoke. Only individuals with alcohol dependence not complicated by liver cirrhosis or nutritional deficiencies were included in
this study. All psychiatric and alcohol use disorder diagnoses are confirmed using the Diagnostic Instrument for Brain Studies that is compliant with the
Diagnostic Statistical Manual of Mental Disorders and has demonstrated reliability [27].
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study, twenty male NF-B enhanced GFP mice, a trans-
genic mouse expressing the enhanced GFP under the
transcriptional control of NF-B cis elements (cis-NF-
BEGFP) [22,23], were treated intragastrically with water
(control, 10 mice) or ethanol (5 g/kg, i.g., 25% ethanol
w/v, 10 mice), daily for 10 days. The mice were sacri-
ficed 24 hr after the last dose of ethanol. For ROS analy-
sis, male C57BL/6 or NF-B enhanced GFP mice (10
mice per group) were treated intragastrically with water
(control) or ethanol (5 g/kg, i.g., 25% ethanol w/v), daily
for 10 days. Mice were injected with dehydroethidium
(10 mg/kg, i.p.) in 0.5% carboxymethyl cellulose at 23.5
hr after the last dose of ethanol. Brains were harvested
30 min later and frozen sections (15 μm) were examined
for hydroethidine oxidation product, ethidium accumu-
lation, by fluorescence microscopy. All experiments
were repeated 2 to 3 times.
Real-time PCR analysis
Total RNA was extracted from the brain samples of
C57BL/6 mice treated with ethanol or water, and
reverse transcribed as described previously [29]. The
primer sequences used in this study were as follows:
NF-B p65 (essential modulator), 5’-GGC GGC ACG
TTT TAC TCT TT-3 ’ (forward) and 5 ’-CCG TCT
CCA GGA GGT TAA TGC-3’ (reverse); b-actin, 5’-
GTA TGA CTC CAC TCA CGG CAA A-3’ (forward)
and 5’-GGT CTC GCT CCT GGA AGA TG-3 ’
(reverse). The SYBR green PCR master mix (Applied
Biosystems, Foster City, CA) was used for real-time
PCR analysis. The relative differences in expression
between groups were expressed using cycle time (Ct)
values normalized with b-actin, and relative differences
between control and treatment groups were calculated
and expressed as relative increases setting control as
100%.
Immunohistochemistry
Mouse brains were fixed with 4% paraformidehide in
Phosphate Buffered Saline (PBS) and processed for
immunostaining as described previously [29]. Human
postmortem brains were processed to Paraffin sections
for immunohistochemistry. Microglia were stained with
rabbit anti-Iba1 antibody. Mouse NOX membrane subu-
nit gp91phox was immunostained with monoclonal anti-
mouse gp91phox or rabbit polyclonal anti-gp91phox IgG.
Human gp91phox was immunostained with goat polyclo-
nal gp91phox antibody. Caspase-3 was immunostained
with polyclonal anti-cleaved caspase-3 antibody. Neu-
rons were stained with Neu-N or MAP2 antibody.
Astrocytes were labeled with GFAP antibody. Immuno-
labeling was visualized by using nickel-enhanced 3,3’-
diaminobenzidinne (DAB) or Alexa Fluor 488 (green) or
555 (red) or 633 (blue) dye.
In situ visualization of O2
- and O2
- - derived oxidant
production
In situ visualization of O2
- and O2
- - derived oxidant
production was assessed by hydroethidine histochemis-
try [19,30]. Mice were injected with dehydroethidium
(10 mg/kg, i.p.) in 0.5% carboxymethyl cellulose at 23.5
hrs after the last dose of ethanol. Brains were harvested
30 min later and frozen sections (15 μm) were examined
for hydroethidine oxidation product, ethidium accumu-
lation, by fluorescence microscopy (excitation 510 nm;
emission 580 nm).
Fluoro-Jade B staining with Neu-N labeling
Brain sections were immunostained with mouse Neu-N
(a neuronal marker) antibody. Immunolabeling was
visualized by using Alexa Fluor 555 dye. Sections were
rinsed three times with PBS and one time with water
before performing Fluoro-Jade B procedure. Sections
stained with Neu-N were mounted on superfrost/plus
microscope slides and air dried overnight. The sections
were rinsed in distilled water for 2 min to rehydrate and
transferred to a solution of 0.06% potassium permanga-
nate for 10 min. The sections were then rinsed in dis-
tilled water for 2 min and placed in a 0.0004% Fluoro-
Jade B solution made by adding 4 ml of a 0.01% stock
solution of Fluoro-Jade B to 96 ml of 0.1% acetic acid.
After 20 min in the Fluoro-Jade B staining solution, the
stained slides were thoroughly washed in distilled water,
dehydrated and coverslipped.
Microscopic quantification
Immunoreactivity of mouse gp91phox and fluorescent
intensity of Fluoro-Jade B and ethidium were quantified
using Bioquant Image Analysis Software (Nashville, TN).
Images were captured on an Olympus BX51 microscope
and Sony DCX-390 video camera at 40X. Light levels
were normalized to preset levels and the microscope,
camera, and software were background corrected to
ensure reliability of image acquisition [31]. In each
region (cortex and dentate gyrus), six random images
from each brain sample were captured within a standard
ROI (Region of Interest), the density of immunostaining
and fluorescence was measured in pixels within this
area (pixels/mm2). Subsequently, the average of the six
measurements was used to represent the immunoreac-
tivity or fluorescence intensity of each sample. When
measuring fluorescence intensity in the cells, we elimi-
nated the background by adjusting threshold to avoid
background staining. For +IR cells counting, a modified
stereological method was used to quantify cells within
regions of interest following immunostaining of brain
sections using the CAST stereological system [32,33].
Specifically, cell density (Nv) of caspase-3 and gp91
phox
+ immunoreactivity (+IR) was determined following the
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optical disector method [34,35], which was calculated as
follows:
Nv =
∑
Q
∑
disector × A(fr)× h
Where ∑Q is the sum of the caspase-3 or gp91phox +
IR cells counted from each disector frame, ∑disector is
the sum of the number of disector frames counted, A
(fr) is the known area associated with each disector
frame, and h is the known distance between two disec-
tor planes (we used 10 μm).
For colabeling study, double or triple stained sections
were digitally photographed with Leica SP2-AOBS con-
focal microscope and analyzed with Leica SP2 LCS
software.
Statistical analysis
The data are expressed as mean ± SEM and statistical
significance was assessed with an ANOVA followed by
Bonferroni’s t-test using the StatView program (Abacus
Concepts, Berkeley, CA). A value of P < 0.05 was con-
sidered statistically significant.
Results
Chronic ethanol increases caspase-3 expression and
Fluoro-Jade B staining
To determine the effect of ethanol exposure on neuro-
degeneration in mice, immunohistochemistry for cleaved
caspase-3 [36] and Fluoro-Jade B histochemistry were
performed on C57BL/6 mouse brain sections treated
with water or ethanol (5 g/kg, i.g.) daily for 10 days.
Ethanol-treated mice showed an increase in activated
caspase-3 immunoreactivity 24 hours after the last dose
of ethanol treatment, compared to water controls (Fig-
ure 1A). The number of activated caspase-3+immunor-
eactive (IR) cells increased 3.1 fold in cortex and 3.5
fold in dentate gyrus in ethanol-treated mice (Figure
1B). To determine if caspase-3+immunoreactivity (+IR)
was neuronal, double immunohistochemistry for cleaved
caspase-3 and Neu-N, a neuronal marker was used.
Confocal microscopy indicated that most activated cas-
pase-3 +IR cells colocalize with Neu-N+IR cells (Figure
1C), suggesting chronic ethanol exposure causes neuro-
nal cell death. Fluoro-Jade B, another cell death marker,
was also used to assess ethanol-induced neurotoxicity
[37]. Brain sections from control animals showed little
or no Fluoro-Jade B staining. However, mouse brains
exposed to chronic ethanol increased 10 fold in cortex
and 7.6 fold in dentate gyrus in intensity of Fluoro-Jade
B positive staining 24 hours after the last dose of etha-
nol treatment compared to water control group (Figure
2A). Confocal microscopy indicated that most Fluoro-
Jade B positive cells were colocalized with Neu-N+IR
(Figure 2B). Both cleaved caspase-3+IR and Fluoro-Jade
B markers suggest chronic ethanol induce neuronal cell
death in C57BL/6 adult mice. The orbitofrontal cortex
(OFC) of human post-mortem brain was assessed using
Fluoro-Jade B. The OFC of human moderate drinking
control brain showed few Fluoro-Jade B cells whereas
the OFC of alcoholic brain showed more labeled cells
(Figure 3). Confocal microscopy found that Fluoro-Jade
B positive cells in human brain were mostly colocalized
with Neu-N, suggesting increased neuronal cell death in
human post-mortem alcoholic brain.
Chronic ethanol induces activation of microglia and
astrocytes
Previous studies have linked activation of microglia, pro-
duction of proinflammatory factors and reactive oxygen
species (ROS) to neurodegeneration [16,29,38]. Our pre-
vious research found that 10 daily doses of ethanol sig-
nificantly increased levels of brain proinflammatory
genes (TNFa and MCP-1, etc.) [9]. To investigate proin-
flammatory responses in this experiment sections were
immunostained with Iba1 microglial antibody. In the
water control group, microglia have a resting morphol-
ogy. Ethanol treated mouse brains showed activated
microglia morphology in multiple brain regions, includ-
ing cortex and dentate gyrus of hippocampus (Figure
4A) 24 h after the last dose of ethanol. Microglia activa-
tion following ethanol treatment is indicated by
increased cell size, irregular shape, intensified Iba1 stain-
ing, and an altered ameboid morphology. Thus, Iba1+
IR morphological assessment indicate ethanol causes
microglial activation.
Astrocyte activation was assessed by morphology using
GFAP, an astrocyte-specific intermediate filament pro-
tein [39,40]. Chronic ethanol treatment increased GFAP
+ IR in cortex and dentate gyrus (Figure 4B) 24 h after
the last dose of ethanol. In addition to these two brain
regions, astroglial activation was also notably observed
in other brain areas, such as substantia nigra and for-
ceps minor corpus callosum in the ethanol treated-mice
(data not shown). Thus, the data together with increased
cell death markers (caspase-3 and Fluoro-Jade B) by
chronic ethanol treatment suggest that astroglial activa-
tion mediate ethanol-induced neurodegeneration.
Chronic ethanol enhances NF-B mRNA and protein
expression
Previous studies have suggested ethanol activates
nuclear factor B (NF-B) transcription inducing
expression of proinflammatory genes [14,41]. To investi-
gate effect of ethanol on NF-B mRNA and protein
expression, C57BL/6 and NF-B-GFP reporter mice
were treated intragastrically with water (control) or
ethanol (5 g/kg, i.g., 25% ethanol w/v) daily for 10 days
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Figure 1 Chronic ethanol increases caspase-3 activation. (A) Representative images of activated caspase-3+immunoreactive (+IR) cells in
cortex and dentate gyrus (DG) from control and ethanol-treated mice. (B) Quantification of caspase-3 immunoreactivity in cortex and DG.
Ethanol-treated mouse brains showed more caspase-3+IR cells than water controls 24 hrs after the last dose of ethanol treatment. (C) Brain
sections from water and ethanol (5 g/kg, i.g., 10 days) treated C57BL/6 mice were double-stained with cleaved caspase-3 and Neu-N (a neuronal
marker) antibodies. Shown are images of cortex and DG for activated caspase-3 (green), Neu-N (red), and colabeling of caspase-3 and Neu-N
(yellow). Confocal microscopy shows that caspase-3 is expressed in Neu-N+IR cells, as shown with arrows indicating the colabeling of caspase-3
and Neu-N in ethanol-treated mice. Control sections show little or not colabeling of caspace-3 and Neu-N+IR cells. Inset is the higher
magnification of arrow pointed cells. ** P < 0.01, compared with the water control mice (n = 10). Scale bar = 30 μm; inset 5 μm.
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Figure 2 Fluoro-Jade B staining in the cortex and dentate gyrus of C57BL/6 mice. Brain sections from C57BL/6 mice treated with either
water or ethanol daily for 10 days were double-stained with Neu-N antibody and Fluoro-Jade B as described in Materials and Methods. Neu-N
immunolabeling was visualized by using Alexa Fluor 555. (A) Fluorescent intensity of Fluoro-Jade B positive cells in cortex and dentate gyrus was
quantified by BioQuant image analysis system. The cortex and DG of chronic ethanol-treated mice had more Fluoro-Jade B positive cells than
water control mice 24 hrs after the last dose of ethanol treatment. These cells are colocalized with Neu-N, a neuronal marker, suggesting
neuronal death. (B) Representative images for Fluoro-Jade B (green), Neu-N (red) and colabeling of Fluoro-Jade B and Neu-N (yellow) from cortex
and dentate gyrus in ethanol-treated mice. ** P < 0.01, compared with the water control mice (n = 10). Scale bar = 30 μm; inset 5 μm.
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Figure 3 Increased Fluoro-Jade B staining in human post-mortem alcoholic brain (A) Representative images from the orbitofrontal
cortex (OFC) of moderate drinking control brain and alcoholic brain stained with Fluoro-Jade B. Brain sections from the OFC of human
post-mortem alcoholics and moderate drinkers were double-labeled with Neu-N antibody and Fluoro-Jade B. Confocal microscopy indicated that
Fluoro-Jade B positive cells were colocalized with Neu-N, suggesting neuronal death Scale bar = 30 μm. (B) Level of fluorescent intensity of Fluoro-
Jade B positive cells was quantified by BioQuant image analysis software. The OFC of human post-mortem alcoholic brain had significant increase
in fluorescent intensity of Fluoro-Jade B positive cells, compared to the OFC of human moderate drinking control brain (** P < 0.01, n = 8).
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Figure 4 Immunohistochemical analysis of microglia and astraglia. Male C57BL/6 mice were treated intragastrically with water or ethanol (5
g/kg, i.g.) daily for 10 days and sacrificed 24 hours following ethanol treatment. Brain sections were stained with Iba1 microglial antibody or
GFAP astroglial antibody. (A) Chronic ethanol exposure induced microglial activation in many brain regions. Images shown are representative of
Iba1+IR cells in cortex and dentate gyrus from control and ethanol groups. In water control mice, most of the microglia were in a resting
morphological shape. However, Iba1+IR cells in ethanol-treated mouse brains were shown by increased cell size, irregular shape, and intensified
Iba1 staining consistent with morphological changes in activated microglia. Scale bar = 200 μm. (B) Images are representative of GFAP+IR cells
in cortex and dentate gyrus from water and ethanol groups. Chronic ethanol markedly increased astroglial activation: upregulation of GFAP
immunoreactivity and morphology of hypertophic astrocytes. Scale bar = 200 μm.
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as before and sacrificed 24 hrs after the last dose of
ethanol. Chronic ethanol significantly increased NF-B-
p65 gene expression in C57BL/6 mouse brain (Figure
5A). In NF-B GFP reporter mice ethanol treatment
markedly increased GFP Fluorescence in multiple brain
regions, such as dentate gyrus (Figure 5B).
Cell phenotype for NF-B activation and ROS produc-
tion was examined using histochemical markers. NF-B
enhanced GFP reporter mice showed green fluorescence.
ROS were detected by red hydroethidine histochemistry
and cell type markers, e.g. Iba1 microglial antibody,
MAP2 neuronal antibody and GFAP astroglial antibody.
Confocal microscopy found that NF-B and ROS were
triple-labeled with Iba1 or MAP2, but not with GFAP
(Figure 5C), indicating ethanol-induced NF-B activa-
tion and ROS production mostly occurred in microglia
and neurons.
Chronic ethanol increases expression of NOX and
production of ROS
NADPH oxidase (NOX) is the enzyme complex respon-
sible for the respiratory burst in phagocytes. Activation
of this enzyme in microglia causes the production of
ROS leading to dopaminergic neurotoxicity [29]. To
determine whether NOX is involved in chronic ethanol
induced neurotoxicity we investigated the expression of
NOX gp91phox, the catalytic subunit of phagocytic oxi-
dase commonly associated with proinflammatory
responses. Cortex and dentate gyrus of ethanol treated
mouse brain had significantly more gp91phox +IR cells,
compared to those of water control brain 24 hrs after
ethanol treatment (Figure 6A). Quantification of
gp91phox +IR indicated that ethanol induced gp91phox
+IR 4.3 fold in cortex and 3.4 fold in DG (Figure 6B).
Chronic ethanol-induced increases in gp91phox expres-
sion remained elevated 1 week after ethanol treatment
(Figure 6C). Thus, ethanol treatment of mice increases
NOX gp91phox expression that persists long after cessa-
tion of drinking.
Human postmortem alcoholic brain histochemistry
showed significant increases in the number of gp91phox
+ IR cells, compared to human moderate drinking con-
trol brain (Figure 7A, B). Double antibody studies with
cell specific markers and confocal microscopy reveal
that gp91phox +IR cells in human postmortem alcoholic
brain are colocalized with a neuronal marker (MAP-2),
a microglial marker (Iba-1), and an astroglial marker
(GFAP) (Figure 7C). These results indicate that alcohol
increases NOX gp91phox expression in both ethanol-
treated mouse brain and human alcoholics consuming
large amounts of alcohol.
To investigate whether induced NOX produces super-
oxide in brain, we used in situ visualization of reactive
oxygen species, e.g. O2
- and O2
--derived oxidant
production of ethidium from hydroethidine in vivo
[19,30]. In vehicle-treated mice, there was little to no
detection of O2
- and O2
--derived oxidant production of
ethidium. In ethanol-treated mice, a significant produc-
tion of O2
- and O2
--derived oxidants was observed 24
hrs after 10 daily doses of ethanol exposure (Figure 8A).
Quantification of the ethidium fluorescence indicates
that ethanol increased O2
- and O2
--derived oxidants
more than 7 fold in cortex and DG, compared to con-
trols (Figure 8B). These findings indicate that ethanol
increases expression of NOX gp91phox and increases the
formation of reactive oxygen species. Human alcoholics
show a similar increase in NOX+IR consistent with
chronic alcohol abuse in humans increasing proinflam-
matory oxidative stress in brain.
The cellular localization of chronic ethanol-induced
activation of NOX and production of ROS
To determine if ROS are found in cells expressing NOX
gp91phox, we performed triple labeling using gp91phox
+IR together with antibodies against the Iba1, a marker
of microglia or Neu-N, a marker of neurons, or GFAP, a
marker of astrocytes on brain sections from the mice
injected with dehydroethidium, an agent detecting ROS.
Confocal microscopy indicated that gp91phox (blue) and
O2
- (red) labeling was not detectable in water control
mouse brains (picture not shown). However, intense
fluorescence of gp91phox and O2
- was observed in etha-
nol treated mouse brains (Figure 9, first and second
panels) 24 h after the last dose of ethanol. Triple-labeled
cells are white due to gp91 (blue), O2 (red) combining
with microglial (Iba1, green) or neuronal (Neu-N, green)
marker proteins (Figure 9), but not with astrocyte GFAP
(pink). These results indicate that chronic ethanol-
induced activation of NOX and production of O2
- pre-
dominantly occurs in microglia and neurons in mouse
brain.
DPI reduces chronic ethanol-induced microglial activation
and ROS generation
In an effort to discern the role of ROS in ethanol-
induced neurotoxicity, we used a NOX inhibitor, Diphe-
nyliodonium (DPI) [42,43]. As the resident innate
immune cells in the brain, microglia are a predominant
source of pro-inflammatory factors [TNFa, MCP-1,
IFN-g and oxidative stress (NO, H2O2, O2
- and OHOO-/
ONOOH)], which are toxic to neurons [44]. To examine
whether ethanol-induced microlgial activation is asso-
ciated with ROS and the consequent neurotoxicity,
C57BL/6 mice were injected with DPI. As shown in Fig-
ure 10, after 10 daily doses of ethanol treatment, micro-
glia appear activated: increased cell size, irregular shape,
and intensified Iba1 staining. Treatment with DPI signif-
icantly reduced microglial activation by ethanol
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Figure 5 Chronic ethanol enhances NF-B mRNA and protein expression. C57BL/6 and NF-B enhanced GFP mice were treated with water
or ethanol (5 g/kg, i.g.) daily for 10 days and sacrificed 24 hrs after the last dose of ethanol. (A) C57BL/6 mouse brain mRNA expression of NF-
B-p65 is significantly increased by 10 doses of ethanol exposure 24 hrs following ethanol treatment compared with water controls, as
determined by real-time PCR. (B) Representative images are from the dentate gyrus of NF-B enhanced GFP mice 24 hrs after water or ethanol
treatment. Ethanol treated mouse brain had more NF-B-GFP (green fluorescence) than water control brain. Scale bar = 20 μm. (C) NF-B
reporter mice were injected with dehydroethidium (10 mg/kg, i.p.) 23.5 hrs after ethanol treatment. Brains were harvested 30 min later and
frozen sections (15 μm) were processed and immunostained for Iba1, Neu-N or GFAP to analyze cell phenotype for NF-B activation and ROS
production. Confocal results reveal that NF-B activation and ROS production predominantly occurred in microglia and neurons as shown by
NF-B (green) and ROS (red) are triple labeled with Iba-1+IR cells (blue) or with MAP-2 +IR neurons (blue). Triple-labeling is shown in write with
arrows. Double-labeled images are shown in yellow with arrowheads indicating the colabeling of NF-B (green) and ROS (red). The images
presented are from dentate gyrus of ethanol treated mice. Scale bar = 10 μm. * P < 0.05, compared with the water control mice.
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Figure 6 Chronic ethanol up-regulates brain NOX subunit gp91phox expression. Brain sections from C57BL/6 mice treated with water or
ethanol (5 g/kg, i.g.) daily for 10 days and sacrificed 24 hrs and 1 week after ethanol exposure were stained with monoclonal mouse gp91phox
antibody. Immunolabeling was visualized by using nickel-enhanced 3,3’-diaminobenzidinne (DAB) for 24 h samples and Alexa Fluor 488 dye
(green) for 1 week samples. (A) The images shown are representative of gp91phox +IR cells in cortex and DG 24 hrs after water and ethanol
exposure. Scale bar = 200 μm. (B) Chronic ethanol significantly increased the level of gp91phox immunoreactivity 24 hrs after ethanol treatment,
as quantified by BioQuant image analysis system. (C) Chronic ethanol-induced increase in gp91phox expression remained elevated at 1 week after
ethanol treatment. Scale bar = 100 μm. ** P < 0.01, compared with the water control mice.
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Figure 7 Increased NOX subunit gp91phox expression in human alcoholic brain. (A) Quantification of gp91phox + IR cells. The orbitofrontal
cortex (OFC) of human postmortem alcoholic brain has a significant increase in the number of gp91phox + IR cells, compared to the OFC of
human moderate drinking control brain (** P < 0.01, n = 8). (B) The representative images from the OFC of moderate drinking control brain and
alcoholic brain stained with gp91phox antibody. Scale bar = 50 μm. (C) Colocalization of NOX subunit gp91phox . Brain sections from the OFC of
human alcoholic brains were double-labeled for gp91phox (red) and MAP-2 (a neuronal marker), Iba1 (a microglial marker), and GFAP (an
astroglial marker) (green) to analyze colabeling by using the Leica SP2 LCS confocal software. Confocal microscopy shows that gp91phox +IR cells
are colocalized with MAP-2, Iba-1, and GFAP+IR cells as shown in yellow, indicating NOX subunit gp91phox is expressed in neurons (the upper
panel), microglia (the middle panel) and astroglia (the lower panel). Scale bar = 10 μm. ** P < 0.01, compared with the OFC of human moderate
drinking control brain.
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exposure. In DPI and ethanol co-treatment group,
microglia showed the resting morphology similar to
those in the water control group. These results suggest
an important role of NOX in ethanol-induced microglia
activation. To analyze the effects of DPI treatment on
ROS, hydroethidine histochemistry was performed.
Exposure of mice to ethanol for 10 days was found to
significantly increase ROS generation (Figure 11A, B),
again providing confirmation that ethanol can elicit
ROS generation in adult C57BL/6 mouse brain. DPI
treatment caused 51% decrease in fluorescence intensity
of O2
- and O2
--derived oxidants, compared with etha-
nol-treated group (Figure 11B), suggesting that NOX-
generated ROS contribute to chronic ethanol-induced
microglial activation.
Inhibition of NOX with DPI prevents ethanol-induced
neurodegeneration
Chronic ethanol increased the number of activated
caspase-3+IR cells by 104% compared to water
control group. DPI alone did not show any effect on
caspase-3 immunolabeling compared to water con-
trols. Co-treatment with DPI and ethanol reduced
ethanol-induced increase in caspase-3+IR cells (Figure
12A). Also, DPI significantly reduced ethanol
increased Fluoro-Jade B fluorescence intensity by
about half (Figure 12B). DPI is a NOX inhibitor. DPI
treatment reduced ROS and cell death markers (cas-
pase-3 and Fluoro-Jade B), so the data suggest that
NOX-generated ROS contribute to chronic ethanol-
induced neurotoxicity.
Figure 8 Chronic ethanol significantly increased O2
- and O2
-
-derived oxidant production. Male C57BL/6 mice were treated
with water or ethanol (5 g/kg, i.g.) daily for 10 days and injected
with dehydroethidium (10 mg/kg, i.p.) 23.5 hrs after the last dose of
ethanol exposure. Brains were harvested 30 min later and frozen
sections (15 μm) were examined for hydroethidine oxidation
product, ethidium accumulation, by fluorescent microscopy. (A)
Representative images of ethidium fluorescence in cortex and
dentate gyrus. In the cortex and DG of control mouse brain,
ethidium fluorescence was minimal (DG image not shown). Both
cortex and DG of ethanol treated mice had significant increases in
ethidium fluorescence. Scale bar = 200 μm. (B) Level of fluorescent
intensity of ethidium positive cells was quantified by BioQuant
image analysis software. Ethanol treatment of C57BL/6 mice showed
significantly increased O2
- and O2
--derived oxidant production in
either cortex or DG, compared with water control mice. ** P < 0.01,
compared with water controls.
Figure 9 Determination of cell phenotype for NOX subunit
gp91phox expression and O2
- production. Cell phenotype was
determined by confocal microscopy of sections triple labeled for
gp91phox (blue), O2
- (red) with Iba-1, or Neu-N or GFAP (green).
C57BL/6 mice were injected with dehydroethidium (10 mg/kg, i.p.)
23.5 hrs after ethanol treatment. Brains were harvested 30 min later
and frozen sections (15 μm) were processed and double-
immunostained for gp91phox and Iba1, gp91phox and Neu-N as well
as gp91phox and GFAP to analyze triple labeling or colabeling by
using the Leica SP2 LCS confocal software. Confocal microscopy
shows that gp91phox +IR cells are triple-labeled with O2
- and Iba1 or
Neu-N, but not with GFAP. Triple-labeled representative images are
shown in white with arrows indicating the triple-labeling of
gp91phox with O2
- and Iba1 (merged, the lower left panel) or
gp91phox with O2
- and Neu-N (merged, the lower middle panel).
Double-labeled representative images are shown in pink with
arrowheads indicating the colabeling of gp91phox with O2
- , but not
with GFAP (merged, the lower right panel). The images presented
are from dentate gyrus of ethanol treated mice. Scale bar = 20 μm.
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Discussion
Chronic binge drinking can cause brain damage, cogni-
tive dysfunction and neurodegeneration. Cerebral white
matter atrophy and neuronal loss in the frontal cortex,
the hypothalamus, and the thalamus are found in alco-
holic brains [1,45]. Binge ethanol treatment of adult rats
induces neuronal damage [8]. We have recently discov-
ered that alcohol increases proinflammatory cytokines
(TNFa, IL-1b), chemokine (MCP-1) and microglial acti-
vation in mouse brain that mimic increases found in
post-mortem human alcoholic brain [9,10]. Here, our
data, for the first time, find that 10 daily binge doses of
ethanol caused significant increases in the staining of
cell death markers: cleaved caspase-3 and Fluoro-Jade B.
Activated caspase-3+immunoreactivity (+IR) is a puta-
tive marker for dying cells [36]. Fluoro-Jade B is an
alternative marker selectively staining degenerating neu-
rons in the central nervous system (CNS) [37]. Our data
found that chronic ethanol increased the number of
activated caspase-3+IR cells 3.1 fold in cortex and 3.5
fold in dentate gyrus (Figure 1). Fluoro-Jade B positive
cells was increased 10 fold in cortex and 7.6 fold in den-
tate gyrus (Figure 2). These results suggest that chronic
ethanol can cause neurodegeneration in adult mice. We
also studied human post-mortem alcoholic frontal cor-
tex, the brain region most associated with alcoholic
neurodegeneration [46-48]. We found that the orbito-
frontal cortex (OFC) of human postmortem alcoholic
brain has significantly more Fluoro-Jade B positive cells
which are colocalized with Neu-N, a neuronal marker,
compared to the OFC of human moderate drinking con-
trol brain. Together, these results indicate that alcohol
can cause neurodegeneration in adult mice that mimics
that found in human alcoholics.
The underlying mechanism of alcohol-induced brain
damage is not well understood. Activation of glial cells
is a critical event in many neuroinflammatory processes
[49,50]. Activation of microglia has been linked to neu-
rodegeneration through the production of neurotoxic
factors, such as proinflammatory cytokines and free
radicals [51,52]. Here we show that 10 doses of ethanol-
treated mouse brain displayed the characteristics of acti-
vation of microglia: increased cell size, irregular shape,
and intensified Iba-1 immunoreactivity (Figure 4A). We
previously reported that chronic ethanol can activate
microglia increasing proinflammatory factors (TNFa, IL-
1b and MCP-1, etc.) [9]. Astroglial activation we report
here is also observed 24 hours after chronic ethanol
treatment (Figure 4B). The activated astroglia were
shown by a marked upregulation of GFAP immunoreac-
tivity along with hypertrophic astrocytes in several brain
regions, including cortex and dentate gyrus. These
results are consistent with Guerri lab’s findings that
show hypertrophic astrocytes as well as increased cas-
pase-3+IR cells in the mice treated with chronic ethanol
administration (10% ethanol, v/v, for 5 months) [11].
Reactive hypertrophic astrogliosis is a marker of neu-
roinflammation. Again, our data support that activation
of microglia and astroglia contribute to chronic ethanol-
induced neuroinflammation and neurodegeneration.
NF-B is a family of transcription factors involved in
regulating cell death/survival, differentiation, and inflam-
mation. Acute ethanol administration has been demon-
strated to activate the NF-B system in the brain, and
this in turn triggers the expression of TNFa as well as
other proinflammatory cytokines and NF-B-regulated
genes [13]. Increases in NF-B DNA-binding activity
during ethanol treatment correlate with the increased
expression of proinflammatory genes in hippocampal-
entorhinal cortex slice cultures [14]. Blockade of NF-B
activation by p65 siRNA or the antioxidant butylated
hydroxytoluene (BHT) reduces the induction of proin-
flammatory TNFa, IL-1b, MCP-1, protease TACE, tissue
plasminogen activator (tPA) and inducible nitric oxide
synthase by ethanol [14].
In rats BHT blocked NF-B-DNA binding and ethanol
neurotoxicity [13]. In this study, we find that 10 doses of
ethanol significantly increase NF-B -p65 gene expres-
sion (Figure 5A) in C57BL/6 mice. Consistent with the
mRNA data, in ethanol treated group, NF-B GFP
Figure 10 Diphenyleneiodonium (DPI) inhibited ethanol-
induced microglial activation. Male C57BL/6 mice were treated
intragastrically with water or ethanol (5 g/kg, i.g.) daily for 10 days.
Diphenyleneiodonium (DPI) (3 mg/kg) was injected intraperitoneally
0.5 hr and 24 hr after the last dose of ethanol. Mice were sacrificed
3 hrs after the last dose of DPI. Brain sections were stained with Iba-
1 antibody. In water control mice, most of the microglia were in a
resting morphological shape. Iba1+IR cells in ethanol-treated mouse
brains were activated as shown by increased cell size, irregular
shape, and intensified Iba1 staining. DPI inhibited ethanol-induced
microglial activation shown in a resting morphological shape. Scale
bar = 200 μm.
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Figure 11 DPI inhibited ethanol-induced production of O2
- and O2
- -derived oxidants. C57BL/6 mice treated with water, ethanol, DPI and
ethanol plus DPI were injected with dehydroethidium (10 mg/kg, i.p.) 2.5 hrs after the last dose of DPI. Brains were harvested 30 min later and
frozen sections (15 μm) were examined for hydroethidine oxidation product, ethidium accumulation, by fluorescent microscopy. (A) The images
demonstrated that ethanol markedly increased production of O2
- and O2
--derived oxidants compared to water controls, and DPI significantly
reduced ethanol-induced production of O2
- and O2
--derived oxidants compared to ethanol-treated group. Scale bar = 200 μm. (B) Level of
fluorescent intensity of ethidium positive cells in cortex was quantified by BioQuant image analysis software. Ethanol treatment of C57BL/6 mice
showed significantly increased O2
- and O2
--derived oxidant production, compared with water control mice. DPI significantly decreased ethanol-
induced increases in the fluorescent intensity of O2
- and O2
--derived oxidant production. ** P < 0.01, compared with water controls. ## P < 0.01,
compared with ethanol-treated group.
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reporter fluorescence was markedly increased in multi-
ple brain regions, such as dentate gyrus in NF-B
enhanced GFP mice (Figure 5B). Increases occurred pre-
dominantly in microglia and neurons. There data sup-
port the hypothesis that ethanol-induced oxidative stress
involves a neuroinflammatory mechanism under the reg-
ulation of NF-B transcription.
Another novel discovery is that for the first time we
show alcohol increases NADPH oxidase gp91phox
(NOX2) in adult mouse brain that mimics that found in
human post-mortem alcoholic brain. NOX gp91phox
remained elevated 1 week after chronic ethanol treat-
ment (Figure 6C). The orbitofrontal cortex (OFC) of
human post-mortem alcoholic brain also had significant
increases in the number of gp91phox + IR cells, com-
pared to the OFC of human moderate drinking control
brain (Figure 7A, B). Confocal microscopy of double
IHC with markers specific for neurons, microglia and
astrocytes indicated that human NOX gp91phox was
expressed in all 3 cell types in alcoholics (Figure 7C).
Previous studies have found increased NOX-proinflam-
matory responses in mice can persist for at least 10
months and longer [38]. The persistence of NOX-proin-
flammatory responses suggests the elevated levels in
human alcoholic brain may represent both recent alco-
hol drinking as well as heavy drinking periods earlier in
the lifetime of the alcoholics studied. We previously
reported increased microglial markers and the chemo-
kine MCP1 in post-mortem human alcoholic brain [10].
These findings are consistent with gene array studies in
post-mortem human brain. One of the most prominent
gene groups altered in frontal cortex and VTA of alco-
holics are ‘immune/stress response genes’ [53,54]. Simi-
larly brain gene array studies in mice implicate pro-
inflammatory genes in brain may as regulators of alco-
hol intake [55]. Thus, our findings are consistent with
others.
Activated NOX produces superoxide. Superoxide for-
mation, assessed by ethidine, was increased by ethanol.
Increased NOX gp91 expression, superoxide formation
in neurons (Figure 9) and increased makers of neuronal
death (Figure 1, 2) are consistent with neuroimmune
activation and oxidative stress mediating the neuronal
toxicity.
Diphenyleneiodonium (DPI) inhibits NADPH-depen-
dent oxidase. Our data found that co-treatment of DPI
and ethanol significantly reduced ethanol induced
microglial activation and ROS production (Figure 10,
11). Also, DPI pretreatment reduced ethanol increased
caspase-3 immunoreactivity and Fluoro-Jade B staining
(Figure 12). These data link NOX-ROS to ethanol-
induced microglial activation and neurodegeneration.
This study supports a role of NOX and ROS in
chronic ethanol-induced neuroinflammation and neuro-
degeneration (Figure 13). The present study and our
previous report [9] find that chronic ethanol induces
microglial activation, increases proinflammatory cyto-
kines (TNFa, IL-1b, IL-6 etc.) and chemokines (MCP-1)
and up-regulates NOX, resulting in production of ROS.
NF-B transcription is activated and generates these
proinflammatory factors (cytokines, chemokines, oxi-
dases, ROS) that amplify NOX-ROS and NF-B signal-
ing cascades (Figure 13). DPI, a NOX inhibitor, reduces
Figure 12 DPI reduced ethanol-induced caspase-3 activation
and Fluoro-Jade B staining. Male C57BL/6 mice were treated
intragastrically with ethanol (5 g/kg, i.g.) daily for 10 days. DPI (3
mg/kg) was injected intraperitoneally 0.5 hr and 24 hr after the last
dose of ethanol. Mice were sacrificed 3 hrs after the last dose of
DPI. Brain sections were stained with polyclonal cleave caspase-3
antibody and Fluoro-Jade B, respectively. (A) Ethanol increased the
number of caspase-3+IR cells. DPI significantly reduced ethanol-
induced increases in the number of caspase-3+IR cells. (B)
Fluorescent intensity of Fluoro-Jade B positive cells in cortex was
quantified by BioQuant image analysis system. Ethanol-treated
mouse brains showed more Fluoro-Jade B positive cells than water-
treated mouse brains. DPI significantly decreased ethanol-induced
increases in the fluorescent intensity of Fluoro-Jade B positive cells.
** P < 0.01, compared with water controls. ## P < 0.01, compared
with ethanol-treated group.
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microglial activation, ROS generation and neuronal
death markers (activated caspase-3 and Fluoro-Jade B).
Therefore, inhibition of NOX and ROS production may
provide improved prevention and treatment for alco-
holics and other neurodegenerative disorders.
Conclusions
Chronic ethanol induces brain NADPH oxidase gp91phox
(NOX2) up-regulation and neurodegeneration in adult
C57BL/6 mice that mimics findings in human alcoholic
brain. Activation of microglia and astrocytes, induction
of NOX and production of ROS contribute to ethanol
neurodegeneration. Inhibition of NOX, ROS and NF-B
may offer hope in prevention and treatment for alco-
holics and other neurodegenerative diseases.
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